| |
| |
|
| Insider
Information: |
Clark William D |
| Relationship: |
President and CEO, Dir... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
472,656 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,002,093 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
472,656 |
|
|
| Total
Value |
$1,002,093 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
Sr. VP, Chief Business... |
2010-02-19 |
168,279 |
2006-11-07 |
0 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
President and CEO, Dir... |
2022-06-02 |
304,377 |
2014-09-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2022-06-02 |
4 |
S |
$0.06 |
$241 |
D/D |
(4,023) |
304,377 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2022-05-31 |
4 |
S |
$0.06 |
$7,234 |
D/D |
(117,244) |
308,400 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2022-04-04 |
4 |
S |
$1.25 |
$4,905 |
D/D |
(3,924) |
369,487 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2022-03-16 |
4 |
S |
$1.10 |
$12,579 |
D/D |
(11,435) |
373,411 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
384,846 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2021-02-17 |
4 |
OE |
$1.66 |
$81,785 |
D/D |
36,498 |
63,750 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2020-11-10 |
4 |
B |
$2.06 |
$9,806 |
D/D |
4,760 |
4,760 |
2.81 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,344 |
27,344 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2020-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,783 |
50,783 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2019-03-15 |
4 |
OE |
$0.54 |
$8,100 |
D/D |
15,000 |
119,931 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2018-01-17 |
4 |
B |
$0.80 |
$20,000 |
D/D |
25,000 |
82,931 |
2.81 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2016-11-07 |
4 |
B |
$3.49 |
$9,772 |
D/D |
2,800 |
52,205 |
2.81 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2015-12-16 |
4 |
B |
$6.45 |
$24,510 |
D/D |
3,800 |
43,607 |
2.81 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2014-12-12 |
4 |
OE |
$2.86 |
$56,648 |
D/D |
19,807 |
39,807 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
President and CEO |
• • – |
2014-09-02 |
4 |
OE |
$2.86 |
$57,200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2010-02-19 |
4 |
S |
$10.65 |
$101,409 |
D/D |
(9,522) |
168,279 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2010-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
177,801 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2009-12-14 |
4 |
S |
$11.05 |
$2,406,431 |
D/D |
(217,749) |
152,801 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2009-12-14 |
4 |
OE |
$0.33 |
$97,827 |
D/D |
295,550 |
370,550 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2009-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2008-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
100,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2008-08-07 |
4 |
B |
$0.99 |
$49,500 |
D/D |
50,000 |
50,000 |
2.74 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2007-10-01 |
4 |
AS |
$13.87 |
$44,384 |
D/D |
(3,200) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, Chief Business Officer |
• – – |
2007-10-01 |
4 |
OE |
$0.33 |
$1,059 |
D/D |
3,200 |
3,200 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
